A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase

Archives of Medical Science

Volumn 11, Issue 6, 2015, Pages 1272-1278

  Wen Jing, Luo ^a,b   Chuan Qiang, Pu ^a   Hong Hua, Li ^b   Xiang Hui, Lu ^a   Jie Xiao, Liu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Defibrase; Experimental autoimmune myositis; Fibrinogen; Guinea pigs; Idiopathic polymyositis

Indexed keywords

BATROXOBIN; CREATINE KINASE; FIBRINOGEN; FREUND ADJUVANT; MYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE EXACERBATION; EXPERIMENTAL AUTOIMMUNE MYOSITIS; FEMALE; FIBRINOGEN BLOOD LEVEL; GUINEA PIG; IMMUNIZATION; INCIDENCE; INFLAMMATION; LABORATORY TEST; MUSCLE TISSUE; MUSCLE WEAKNESS; MYOSITIS; NONHUMAN; PORCINE MODEL; TISSUE SECTION;

EID: 84949765210     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2015.52883     Document Type: Article

References (32)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82.
2. Matsubara S, Takamori M. Experimental allergic myositis: strain 13 guinea pig immunised with rabbit myosin B fraction. Acta Neuropathol 1987; 74: 158-62.
3. Smith PD, Partridge TA. Macrophage migration inhibition studies of lymphocytes taken from guinea-pigs suffering from experimental polymyositis. Clin Exp Immunol 1976; 25: 133-8.
4. Momeni M, Carlier C, Baele P, et al. Fibrinogen concentration significantly decreases after on-pump versus off-pump coronary artery bypass surgery: A systematic point-of-care ROTEM analysis. J Cardiothor Vasc Anesth 2013; 27: 5-11.
5. Collins J, van Pijkeren JP, Svensson L, et al. Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein. Mol Microbiol 2012; 85: 862-77.
6. Ma A, Pan X, Xing Y, Wu M, Wang Y, Ma C. Elevation of serum CXCL16 level correlates well with atherosclerotic ischemic stroke. Arch Med Sci 2014; 10: 47-52.
7. Profumo A, Turci M, Damonte G, et al. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration. Biochemistry 2003; 42: 12335-48.
8. Fibrinogen Studies C, Danesh J, Lewington S, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294: 1799-809.
9. Jensen T, Kierulf P, Sandset PM, et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thrombosis Haemostasis 2007; 97: 822-9.
10. Polterauer S, Grimm C, Seebacher V, et al. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: A multicenter study. Oncologist 2009; 14: 979-85.
11. Gur-Wahnon D, Mizrachi T, Maaravi-Pinto FY, et al. The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention. J Neuroinflam 2013; 10: 124.
12. Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K. Inflammatory markers in patients with internal carotid artery stenosis. Arch Med Sci 2013; 9: 254-60.
13. Kojima T, Tanuma N, Aikawa Y, Shin T, Sasaki A, Matsumoto Y. Myosin-induced autoimmune polymyositis in the rat. J Neurol Sci 1997; 151: 141-8.
14. Allenbach Y, Solly S, Gregoire S, et al. Role of regulatory T cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 2009; 174: 989-98.
15. Katsumata Y, Harigai M, Sugiura T, et al. Attenuation of experimental autoimmune myositis by blocking ICOSICOS ligand interaction. J Immunol 2007; 179: 3772-9.
16. Nakano J, Yoshimura T, Okita M, et al. Laminin-induced autoimmune myositis in rats. J Neuropathol Exp Neurol 2005; 64: 790-6.
17. Wang H, Schultz K, Elias K, Stachowski M, Loose C. Anti-infection trauma devices with drug-releasing and non-Fouling surface modification. J Orthop Trauma 2014; 28 Suppl. 1: S28-31.
18. Cruz-Topete D, Iwaki T, Ploplis VA, Castellino FJ. Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice. J Pathol 2006; 210: 325-33.
19. Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Iaina-Levin N, Kobus G, Dobrzycki S. Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate. Arch Med Sci 2011; 7: 658-64.
20. Zhang W, Huang W, Jing F. Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med 2013; 4: 141-7.
21. Akassoglou K, Adams RA, Bauer J, et al. Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proc Natl Acad Sci USA 2004; 101: 6698-703.
22. Gay FW. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen. Clin Neurol Neurosurg 2006; 108: 234-40.
23. Akassoglou K, Yu WM, Akpinar P, Strickland S. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 2002; 33: 861-75.
24. Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994; 47: 129-33.
25. Altieri DC. Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost 1999; 82: 781-6.
26. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-94.
27. Tworek D, Kuna P, Mlynarski W, Gorski P, Pietras T, Antczak A. MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Med Sci 2013; 9: 849-53.
28. Zwierzchowski TJ, Stasikowska-Kanicka O, Janus J, Konecki W, Danilewicz M, Fabis J. Assessment of apoptosis, MMP-1, MMP-3, TIMP-2 expression and mechanical and biochemical properties of fresh rabbit's medial meniscus stored two weeks under tissue culture conditions. Arch Med Sci 2014; 10: 167-73.
29. Lluis F, Roma J, Suelves M, et al. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 2001; 97: 1703-11.
30. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann New York Acad Sci 1994; 732: 31-41.
31. Schoser BG, Blottner D, Stuerenburg HJ. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers. Acta Neurol Scand 2002; 105: 309-13.
32. Kieseier BC, Schneider C, Clements JM, et al. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 2001; 124: 341-51.